(Q44792568)
Statements
1 reference
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group (English)
1 reference
1 reference
E F Smit
1 reference
M de Jonge
1 reference
E Dansin
1 reference
E Briasoulis
1 reference
A Ardizzoni
1 reference
J-Y Douillard
1 reference
D Spaeth
1 reference
D Lacombe
1 reference
B Baron
1 reference
P Bachmann
1 reference
P Fumoleau
1 reference
EORTC-New Drug Development Group
1 reference
1 March 2004
1 reference
1 reference
40
1 reference
5
1 reference
667-672
1 reference
Identifiers
1 reference
1 reference